Home

Novartis Venture Fund

Novartis Venture Fund

Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. They balance the therapeutic focus with investments in medical devices, diagnostics, or drug delivery systems. In their investments, they look for unmet needs and clinical impact, novel proprietary science, an understanding of mechanism, management and board experience, and capital efficiency in the program. Novartis Venture Fund prefers to have their initial investment at the early stage to build the company and follow with additional investment in pace with the company's progress.
Investor Type:
Corporate VC
HQ Location:
Switzerland
Investment Areas:
Finance, Therapeutics, Venture Capital, Investing, Life Science
Typical Investment:
€100k-€1.5M
Funding Stage:
Pre-Seed / Seed, Series A/B, Series C & Beyond
Contact Email:
[email protected]